Molecular Imaging and Theranostics of Cancer

癌症的分子成像和治疗诊断学

基本信息

  • 批准号:
    10693873
  • 负责人:
  • 金额:
    $ 96.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-04 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Achieving cancer cure, or even control, continues to be a major unanswered challenge in health care despite the remarkable technological advances of the 21st century. Advances in multi-modal noninvasive molecular and functional imaging are providing unique opportunities to expand our understanding of cancer, an understanding that is critical to developing effective and cancer specific treatments. In this resubmission I have chosen three interactive focus areas within the tumor microenvironment (TME), the tumor macroenvironment (TMacE), and Theranostics, that will be pursued in triple negative breast cancer (TNBC) and pancreatic ductal adenocarcinoma (PDAC) human tumor xenografts and syngeneic tumors in immune competent mice. In the TME focus, we will use imaging to expand our understanding of the focal adhesion kinase (FAK) mechanotransduction pathway in the metastatic cascade that will include developing PET imaging probes to detect FAK noninvasively. FAK also plays a role in tumor immune suppression. In the TMacE focus we will expand our efforts in understanding PDAC induced cachexia that results in a wide range of symptoms affecting the function of organs such as muscle, liver, brain, and heart, causing significant morbidity. The tumor secretome holds the key to this syndrome by influencing the `macroenvironment'. We will focus on characterizing the tumor interstitial fluid (TIF) in preclinical PDAC xenograft models to develop biomarkers of cachexia and identify potential metabolic targets that will be pursued through the Theranostic focus. In the Theranostic focus we will direct our efforts and expertise in imaging and NP technology to improve the outcome of checkpoint inhibitors in TNBC and PDAC. Lack of effector T-cell tumor infiltration has been identified as a major cause of the poor response to these inhibitors. We will use FDA approved poly(lactic-co-glycolic acid) PLGA to create cancer cell membrane (CCM) coated `immunosome' NPs embedded with granulocyte macrophage colony-stimulating factor (GM-CSF) to increase effector T cell tumor infiltration, and apply molecular imaging to detect the biodistribution of the NPs and the changes in T cell infiltration. Ultimately we want to use the patients own cancer cells to synthesize the NPs for personalized medicine. Since FAP-α expressing cancer associated fibroblasts (CAFs) are known to create an immune suppressive TME, we will use anti-FAP-α antibody conjugated to the near infrared (NIR) dye IR700 to detect CAFS with NIR imaging and eliminate them selectively in the tumor with PIT. If PIT of FAP-α expressing CAFs results in increased cytotoxic T cells in tumors, this may have significant applications in combination with checkpoint inhibitor treatment. We will use siRNA delivery with dextran based biocompatible NPs to downregulate FAK, and metabolic targets identified in the TMacE focus. I have built a strong network of collaborators that include clinical oncologists, radiologists, pathologists and surgeons that will ensure the rapid translation of the research conducted through the R35 award to benefit cancer detection and treatment.
尽管如此,实现癌症治愈,甚至控制,仍然是卫生保健领域一个悬而未决的重大挑战

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model.
  • DOI:
    10.3390/cancers14030619
  • 发表时间:
    2022-01-26
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Jin J;Sivakumar I;Mironchik Y;Krishnamachary B;Wildes F;Barnett JD;Hung CF;Nimmagadda S;Kobayashi H;Bhujwalla ZM;Penet MF
  • 通讯作者:
    Penet MF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zaver M. Bhujwalla其他文献

Low-dose temozolomide selectively increases glioblastoma’s vascular permeability, tumor microenvironment penetration and the killing potential of systemic actinium-225 α-particle dendrimer-radioconjugates improving treatment efficacy
  • DOI:
    10.1007/s00259-025-07332-w
  • 发表时间:
    2025-05-14
  • 期刊:
  • 影响因子:
    7.600
  • 作者:
    Rajiv Ranjit Nair;Aira Sarkar;Pooja Hariharan;Kathleen L. Gabrielson;Tony Wu;Chang Liu;Anjali Sharma;Wathsala Liyanage;Zaver M. Bhujwalla;Marie-France Penet Vidaver;Rangaramanujam M. Kannan;Stavroula Sofou
  • 通讯作者:
    Stavroula Sofou
Molecular and functional imaging insights into the role of hypoxia in cancer aggression
  • DOI:
    10.1007/s10555-019-09788-3
  • 发表时间:
    2019-03-06
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Samata Kakkad;Balaji Krishnamachary;Desmond Jacob;Jesus Pacheco-Torres;Eibhlin Goggins;Santosh Kumar Bharti;Marie-France Penet;Zaver M. Bhujwalla
  • 通讯作者:
    Zaver M. Bhujwalla
Artificial neural network detection of pancreatic cancer from proton (1H) magnetic resonance spectroscopy patterns of plasma metabolites
基于血浆代谢物质子(1H)磁共振波谱模式的胰腺癌人工神经网络检测
  • DOI:
    10.1038/s43856-024-00727-0
  • 发表时间:
    2025-01-21
  • 期刊:
  • 影响因子:
    6.300
  • 作者:
    Meiyappan Solaiyappan;Santosh Kumar Bharti;Raj Kumar Sharma;Mohamad Dbouk;Wasay Nizam;Malcolm V. Brock;Michael G. Goggins;Zaver M. Bhujwalla
  • 通讯作者:
    Zaver M. Bhujwalla

Zaver M. Bhujwalla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zaver M. Bhujwalla', 18)}}的其他基金

The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10059035
  • 财政年份:
    2020
  • 资助金额:
    $ 96.24万
  • 项目类别:
The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10405098
  • 财政年份:
    2020
  • 资助金额:
    $ 96.24万
  • 项目类别:
The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10170305
  • 财政年份:
    2020
  • 资助金额:
    $ 96.24万
  • 项目类别:
The Tumor Microenvironment in Nanoparticle Delivery and Function
纳米颗粒递送和功能中的肿瘤微环境
  • 批准号:
    10617333
  • 财政年份:
    2020
  • 资助金额:
    $ 96.24万
  • 项目类别:
Molecular Imaging and Theranostics of Cancer
癌症的分子成像和治疗诊断学
  • 批准号:
    10242814
  • 财政年份:
    2017
  • 资助金额:
    $ 96.24万
  • 项目类别:
Molecular Imaging Reagents for Prostate Cancer Theranostics
用于前列腺癌治疗诊断的分子成像试剂
  • 批准号:
    10226208
  • 财政年份:
    2017
  • 资助金额:
    $ 96.24万
  • 项目类别:
Molecular Imaging and Theranostics of Cancer
癌症的分子成像和治疗诊断学
  • 批准号:
    10455724
  • 财政年份:
    2017
  • 资助金额:
    $ 96.24万
  • 项目类别:
Molecular Imaging of Cachexia in Pancreatic Cancer
胰腺癌恶病质的分子影像
  • 批准号:
    9026680
  • 财政年份:
    2015
  • 资助金额:
    $ 96.24万
  • 项目类别:
Decoy nanoparticles to disrupt cancer cell-stromal cell networks
诱饵纳米颗粒破坏癌细胞-基质细胞网络
  • 批准号:
    9102034
  • 财政年份:
    2015
  • 资助金额:
    $ 96.24万
  • 项目类别:
Imaging Hypoxia and Cancer Stem Cells
缺氧和癌症干细胞成像
  • 批准号:
    8078137
  • 财政年份:
    2009
  • 资助金额:
    $ 96.24万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 96.24万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了